SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics.

Vekemans, J; Moorthy, V; Friede, M; Alderson, MR; Sobanjo-Ter Meulen, A; Baker, CJ; Heath, PT; Madhi, SA; Mehring-Le Doare, K; Saha, SK; et al. Vekemans, J; Moorthy, V; Friede, M; Alderson, MR; Sobanjo-Ter Meulen, A; Baker, CJ; Heath, PT; Madhi, SA; Mehring-Le Doare, K; Saha, SK; Schrag, S; Kaslow, DC (2019) Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics. Vaccine, 37 (50). pp. 7391-7393. ISSN 1873-2518 https://doi.org/10.1016/j.vaccine.2017.09.087
SGUL Authors: Heath, Paul Trafford Le Doare, Kirsty

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (231kB) | Preview

Abstract

Group B streptococcus, found in the vagina or lower gastrointestinal tract of about 10-40% of women of reproductive age, is a leading cause of early life invasive bacterial disease, potentially amenable to prevention through maternal immunization during pregnancy. Following a consultation process with global stakeholders, the World Health Organization is herein proposing priority research and development pathways and preferred product characteristics for GBS vaccines, with the aim to facilitate and accelerate vaccine licensure, policy recommendation for wide scale use and implementation.

Item Type: Article
Additional Information: © 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords: Group B streptococcus, Maternal immunization, Vaccine, Group B streptococcus, Maternal immunization, Vaccine, 06 Biological Sciences, 07 Agricultural And Veterinary Sciences, 11 Medical And Health Sciences, Virology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Vaccine
ISSN: 1873-2518
Language: eng
Dates:
DateEvent
28 November 2019Published
2 February 2018Published Online
28 September 2017Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
001World Health OrganizationUNSPECIFIED
OPP1134011Bill and Melinda Gates Foundationhttp://dx.doi.org/10.13039/100000865
PubMed ID: 29398277
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/109652
Publisher's version: https://doi.org/10.1016/j.vaccine.2017.09.087

Actions (login required)

Edit Item Edit Item